Get the Stockscreener App
3.66
3.68%
0.13
Atea Pharmaceuticals Inc stock is traded at $3.66, with a volume of 739.43K.
It is up +3.68% in the last 24 hours and up +6.71% over the past month.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
See More
Previous Close:
$3.53
Open:
$3.56
24h Volume:
739.43K
Relative Volume:
1.91
Market Cap:
$290.45M
Revenue:
$351.37M
Net Income/Loss:
$-174.01M
P/E Ratio:
-1.7681
EPS:
-2.07
Net Cash Flow:
$-126.94M
1W Performance:
+4.57%
1M Performance:
+6.71%
6M Performance:
+18.45%
1Y Performance:
-3.17%
1-Day Range:
$3.56
$3.86
1-Week Range:
$3.45
$3.86
52-Week Range:
$2.455
$4.145
Atea Pharmaceuticals Inc Stock (AVIR) Company Profile
Name
Atea Pharmaceuticals Inc
Sector
Industry
Phone
857-204-8109
Address
225 FRANKLIN STREET, BOSTON
Compare AVIR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVIR
Atea Pharmaceuticals Inc
|
3.66 | 280.13M | 351.37M | -174.01M | -126.94M | -2.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Atea Pharmaceuticals Inc Stock (AVIR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Aug-10-23 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-06-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-18-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Oct-20-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-05-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-25-20 | Initiated | Evercore ISI | Outperform |
| Nov-24-20 | Initiated | JP Morgan | Overweight |
| Nov-24-20 | Initiated | Morgan Stanley | Overweight |
| Nov-24-20 | Initiated | William Blair | Outperform |
View All
Atea Pharmaceuticals Inc Stock (AVIR) Latest News
Can volume confirm reversal in Atea Pharmaceuticals Inc.July 2025 Patterns & Verified Chart Pattern Trade Signals - Newser
Is It Too Early to Call Recovery in Atea Pharmaceuticals Inc.2025 Trading Volume Trends & High Return Trade Opportunity Guides - newsyoung.net
Signal strength of Atea Pharmaceuticals Inc. stock in tech scannersEarnings Miss & Long-Term Growth Stock Strategies - Newser
Predicting Atea Pharmaceuticals Inc. trend using moving averagesJuly 2025 Earnings & Entry and Exit Point Strategies - Newser
Intraday pattern recognizer results for Atea Pharmaceuticals Inc.Options Play & Verified Swing Trading Watchlist - Newser
Volatility clustering patterns for Atea Pharmaceuticals Inc.July 2025 Volume & Growth Focused Stock Reports - Newser
Analyzing net buyer seller activity in Atea Pharmaceuticals Inc.Earnings Recap Summary & Consistent Return Investment Signals - Newser
Atea Pharmaceuticals Inc. stock daily chart insightsQuarterly Risk Review & Weekly Stock Breakout Alerts - Newser
Regression analysis insights on Atea Pharmaceuticals Inc. performanceForecast Cut & Free Technical Pattern Based Buy Signals - Newser
Multi factor analysis applied to Atea Pharmaceuticals Inc.New Guidance & Safe Entry Point Alerts - Newser
Atea Pharmaceuticals Inc. stock momentum explainedJuly 2025 Levels & Low Risk Entry Point Guides - Newser
Using data filters to optimize entry into Atea Pharmaceuticals Inc.Weekly Trading Summary & AI Forecast Swing Trade Picks - Newser
Is Atea Pharmaceuticals Inc. trending in predictive chart modelsMarket Activity Report & Real-Time Chart Breakout Alerts - Newser
Developing predictive dashboards with Atea Pharmaceuticals Inc. dataWeekly Trend Report & Fast Moving Market Watchlists - Newser
Order flow analysis tools used on Atea Pharmaceuticals Inc.Gold Moves & Real-Time Price Movement Reports - Newser
Technical signs of recovery in Atea Pharmaceuticals Inc.Watch List & Target Return Focused Picks - Newser
What the charts say about Atea Pharmaceuticals Inc. today2025 Short Interest & Fast Gaining Stock Reports - Newser
Published on: 2025-08-19 01:45:06 - Newser
Atea Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SayPortfolio Performance Summary & Fast Moving Stock Trade Plans - Newser
Using data tools to time your Atea Pharmaceuticals Inc. exit2025 Big Picture & Breakout Confirmation Trade Signals - Newser
How to build a custom watchlist for Atea Pharmaceuticals Inc.July 2025 Volume & Weekly Market Pulse Alerts - Newser
Will breakout in Atea Pharmaceuticals Inc. lead to full recoveryWeekly Trade Report & Weekly High Potential Stock Alerts - Newser
Visualizing Atea Pharmaceuticals Inc. stock with heatmapsQuarterly Earnings Report & Fast Exit/Entry Strategy Plans - Newser
Atea Pharmaceuticals Inc. stock volume spike explainedWeekly Stock Report & Safe Swing Trade Setups - Newser
What earnings revisions data tells us about Atea Pharmaceuticals Inc.July 2025 Closing Moves & Target Return Focused Stock Picks - Newser
How institutional ownership impacts Atea Pharmaceuticals Inc. stockTrade Risk Summary & High Accuracy Trade Alerts - Newser
What Fibonacci levels say about Atea Pharmaceuticals Inc. reboundJuly 2025 Summary & Risk Managed Investment Signals - Newser
Will Atea Pharmaceuticals Inc. price bounce be sustainableExit Point & Pattern Based Trade Signal System - Newser
Published on: 2025-08-17 06:07:26 - metal.it
Institutional scanner results for Atea Pharmaceuticals Inc.Weekly Profit Report & Free Daily Entry Point Trade Alerts - Newser
What candlestick patterns are forming on Atea Pharmaceuticals Inc.Breakout Watch & Real-Time Chart Pattern Alerts - Newser
Is Atea Pharmaceuticals Inc. meeting your algorithmic filter criteriaJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - Newser
Atea Pharmaceuticals’ Earnings Call Highlights HCV Progress - MSN
What makes Atea Pharmaceuticals Inc. stock price move sharply2025 Support & Resistance & Safe Entry Trade Signal Reports - Newser
Quantitative breakdown of Atea Pharmaceuticals Inc. recent moveProfit Target & Free High Return Stock Watch Alerts - Newser
Atea Pharmaceuticals Inc Stock (AVIR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Atea Pharmaceuticals Inc Stock (AVIR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BERGER FRANKLIN M | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
506,497 |
| Duncan Barbara Gayle | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Polsky Bruce | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
95,206 |
| Adams Jerome M. | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Lucidi Bruno | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
112,750 |
| BERGER FRANKLIN M | Director |
Dec 10 '24 |
Sale |
2.85 |
359,606 |
1,023,475 |
451,897 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):